Skip to content

Dedicated Breast CT for Diagnosis of Breast Cancer.

Dedicated Breast CT for Diagnosis of Breast Cancer. - Breast CT.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52995
Enrollment
340
Registered
2016-01-20
Start date
2016-10-21
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Mamma carcinoma

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Women age 35 or older - Women scheduled to undergo a diagnostic work-up following an abnormal screening mammogram (BI-RADS 0) with the suspicious finding NOT located in the axillary tail of the breast. - Women who underwent diagnostic work-up following an abnormal screening mammogram and were assigned a BI-RADS 4 or 5 due to soft tissue lesions, or due to microcalcifications with the suspicious finding NOT located in the axillary tail of the breast.

Exclusion criteria

Exclusion criteria: - Women who do not meet the inclusion criteria - Women with suspected or confirmed pregnancy - Women who have had bilateral mastectomy - Women whose suspicious lesion is located in the axillary tail - Women with prior breast cancer or breast biopsy in the recalled breast in the last 12 months - Women with palpable lesions - Women who are breastfeeding - Women who are very frail and unable to cooperate - Women who cannot give informed consent - Male subjects

Design outcomes

Primary

MeasureTime frame
Difference in ROC area under the curve of breast CT vs. standard work-up for diagnosis of breast cancer.

Secondary

MeasureTime frame
Sub-analysis for difference in ROC area under the curve of breast CT vs. standard work-up for diagnosis of breast cancer divided by type of lesion.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)